Lisdexamfetamine, sold in the UK as Elvanse, is a once-daily amphetamine-type stimulant and prodrug — meaning it becomes active only after the body converts it. It's generally considered the closest UK-licensed relative to Adderall.

What it is and how it's used

Lisdexamfetamine treats ADHD in both children and adults by increasing dopamine and noradrenaline activity in the brain, improving attention regulation and impulse control. It's prescribed following formal ADHD diagnosis. For adults, NICE guidance lists it alongside methylphenidate as a co-first-line stimulant option; for children aged 5 and over, it's generally considered after a methylphenidate trial hasn't given sufficient benefit.

Medication class and mechanism

Lisdexamfetamine is an amphetamine-type stimulant, but with a distinctive feature: it's a prodrug. As taken, the compound is pharmacologically inactive. It's converted into dexamfetamine — the active stimulant — primarily through enzymatic action in red blood cells after oral absorption. This conversion step is rate-limiting, which produces a smoother, more gradual rise and fall in effect across the day compared with taking an active amphetamine compound directly, and means the medication's release profile can't be accelerated by routes of administration that bypass normal absorption.

UK brand and formulation

Sold in the UK as Elvanse, available in a range of capsule strengths, taken once daily, typically in the morning. There's also an Elvanse chewable tablet formulation licensed for children who have difficulty swallowing capsules.

Prescription status in the UK

Lisdexamfetamine is a Schedule 2 Controlled Drug under UK law. It requires a formal ADHD diagnosis and prescription from a qualified specialist (with ongoing prescribing potentially transferring to a GP under shared care), and is available on the NHS and privately.

Common considerations

  • As a once-daily medication, Elvanse tends to suit people who prefer simpler daily dosing over multiple-dose regimens.
  • Appetite suppression, particularly around meal times when the medication is most active, is commonly reported — timing and meal planning strategies are often discussed with prescribers.
  • Sleep difficulties can occur if the dose is active too late in the day; dosing time is usually adjusted to manage this.
  • Effects generally build gradually after the first dose and may take some days to fully assess.

Safety and warnings

As with all amphetamine-type stimulants, lisdexamfetamine isn't suitable for everyone — certain cardiovascular conditions, some psychiatric history, and other factors are screened for before prescribing. Cardiovascular monitoring continues through treatment. It is illegal to possess or supply lisdexamfetamine without a valid prescription, and doses should never be adjusted without prescriber guidance.

Starting treatment and titration

As with other stimulant ADHD medications, lisdexamfetamine is started at a low dose and increased gradually under specialist supervision, typically over several weeks, until an effective dose with manageable side effects is found. Because it's once-daily, dose changes are usually easier to track than with multi-dose medications — but they should still only be made by your prescriber, never adjusted independently based on how a particular day feels.

Review appointments during titration generally cover effectiveness (is it helping with the target symptoms?), side effects (appetite, sleep, mood, cardiovascular measures), and practical factors like dosing time. Many people continue fine-tuning dose and timing even after the initial titration period, as life circumstances change.

How it compares to Adderall

Both Adderall and lisdexamfetamine involve amphetamine-type mechanisms, but they're structurally and pharmacologically different products. See our full Adderall vs Elvanse comparison for a detailed breakdown, or the ADHD medication overview for how it fits alongside the UK's other treatment options.

Sources: EMC — Elvanse SmPC · NICE NG87.